Act Advisors, Llc. Heron Therapeutics, Inc. Transaction History
Act Advisors, Llc.
- $179 Million
- Q1 2025
A detailed history of Act Advisors, Llc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Act Advisors, Llc. holds 25,581 shares of HRTX stock, worth $49,371. This represents 0.03% of its overall portfolio holdings.
Number of Shares
25,581
Previous 25,581
-0.0%
Holding current value
$49,371
Previous $39,000
46.15%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
172Shares Held
114MCall Options Held
2MPut Options Held
32.4K-
Rubric Capital Management LP New York, NY26.7MShares$51.6 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$16.4 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$16.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$15.7 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13.5 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $229M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...